These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Bortezomib in combination with dexamethasone and subsequent thalidomide for newly-diagnosed multiple myeloma: a Chinese experience. Zheng W; Wei G; Ye X; He J; Li L; Wu W; Shi J; Zhang J; Huang W; Xie W; Luo Y; Xue X; Lin M; Huang H; Cai Z Leuk Res; 2009 Dec; 33(12):1615-8. PubMed ID: 19773080 [TBL] [Abstract][Full Text] [Related]
33. Asymptomatic significant patent foramen ovale: giving patent foramen ovale management back to the cardiologist. Rigatelli G; Cardaioli P; Chinaglia M Catheter Cardiovasc Interv; 2008 Mar; 71(4):573-7. PubMed ID: 18307240 [TBL] [Abstract][Full Text] [Related]
34. Arterial and venous thrombotic complications with thalidomide in multiple myeloma. Alkindi S; Dennison D; Pathare A Arch Med Res; 2008 Feb; 39(2):257-8. PubMed ID: 18164975 [No Abstract] [Full Text] [Related]
36. Paradoxical embolism through the patent foramen ovale--the elderly is where the money is. Meier B Catheter Cardiovasc Interv; 2008 Dec; 72(7):971-2. PubMed ID: 19021283 [No Abstract] [Full Text] [Related]
37. Thalidomide-associated thrombosis in the treatment of HIV-associated severe aphthous disease: a case report and review of the literature. Hodowanec AC; Han A; Barker DE; Rubinstein PG; Max B J Int Assoc Physicians AIDS Care (Chic); 2012; 11(6):345-7. PubMed ID: 22930795 [TBL] [Abstract][Full Text] [Related]
38. Anticoagulation regimens for thalidomide and lenalidomide. Zangari M Clin Adv Hematol Oncol; 2006 Sep; 4(9):658-9. PubMed ID: 17099621 [No Abstract] [Full Text] [Related]
40. Frequency of thromboembolic events associated with thalidomide in the non-cancer setting: a case report and review of the literature. Fabi SG; Hill C; Witherspoon JN; Boone SL; West DP J Drugs Dermatol; 2009 Aug; 8(8):765-9. PubMed ID: 19663116 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]